MiMedx Group, Inc

MDXGNASDAQ • USD
3.21 USD
↘ 0.03 (0.93%)AT CLOSE (03:59 PM EST)
3.21
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EST)
Post Market
AS OF 07:59 PM EST
3.21
↗ 0.00 (0.00%)
🔴Market: CLOSED

MiMedx Group, Inc (MDXG) trades at $3.21 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.25
High?$3.29
Low?$3.16
Prev. Close?$3.24
Volume?1.1M
Avg. Volume?1.6M
VWAP?$3.22
Rel. Volume?0.71x
Bid / Ask
Bid?$3.00 × 200
Ask?$3.30 × 100
Spread?$0.30
Midpoint?$3.15
Valuation & Ratios
Market Cap?468.4M
Shares Out?145.9M
Float?114.5M
Float %?78.6%
P/E Ratio?N/A
P/B Ratio?2.22
EPS?-$0.13
Dividend?0.35%
Ex-Dividend?N/A
News
Profile
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Employees
808
Market Cap
468.4M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2007-08-22
Address
1775 W OAK COMMONS COURT, NE
MARIETTA, GA 30062
Phone: (770) 651-9100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
8
Short Sent.?
60
Piotroski F-Score?2/9Weak
Altman Z-Score?6.34Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.83%Elevated
Short Interest?9.0M
Days to Cover?4.4
Free Float114.5M
Avg Daily Volume2.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.35Strong
Quick Ratio?3.84Strong
Cash Ratio?2.81Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
93/100
P/E?
N/A▾
P/B?
Peers
100
S&P
69
2.22CHEAP▾
P/S?
Peers
100
S&P
78
1.54CHEAP▾
P/FCF?
Peers
100
S&P
40
24.5FAIR▾
EV/EBITDA?
S&P
97
-20.1CHEAP▾
EV/Sales?
Peers
100
S&P
90
1.14CHEAP▾
Returns & Efficiency
ROE?
S&P
9
-9.1%WEAK▾
ROA?
S&P
3
-7.2%WEAK▾
Cash Flow & Enterprise
FCF?$19.1M
Enterprise Value?$347.6M
Fundamentals ratios updated end of day